AIM Biotech offers a modular platform to co-culture multiple cell types in discrete 3D and 2D channels for research, drug development and targeted therapeutics.
Menu
AIM Biotech offers a modular platform to co-culture multiple cell types in discrete 3D and 2D channels for research, drug development and targeted therapeutics.
Wavemaker is Southeast Asia’s leading early-stage venture capital firm investing in enterprise and deep tech companies.
Wavemaker Partners Copyright 2026 © All Rights Reserved